Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
cardiology
SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding
29 mars 2025 12h32 HE
|
SERB Pharmaceuticals
PLEASANTON, CA, March 29, 2025 (GLOBE NEWSWIRE) -- SFJ Pharmaceuticals (SFJ) and SERB Pharmaceuticals (SERB) announced today the final results of the pivotal Phase 3 REVERSE-IT trial designed to...
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
24 mars 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience as CCO
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
19 mars 2025 08h01 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA...
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
10 mars 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
03 mars 2025 07h31 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
Heartflow Unveils Bold New Vision for Management of Coronary Artery Disease
25 févr. 2025 08h00 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the global leader in AI technology for coronary artery disease (CAD) management, today introduced its new brand identity...
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs
03 févr. 2025 07h00 HE
|
George Medicines
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs London, UK, 3 February 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing...
Stereotaxis Announces First GenesisX Robotic System Order
30 janv. 2025 08h09 HE
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has...
Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology
14 janv. 2025 07h21 HE
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
13 janv. 2025 08h00 HE
|
SS Innovations
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3